Total Payments
$9,151
2024 Payments
$93.00
Companies
54
Transactions
541
Medicare Patients
14,531
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$9,084 (99.3%)
Education$50.86 (0.6%)
Consulting$16.71 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,084 | 532 | 99.3% |
| Education | $50.86 | 8 | 0.6% |
| Consulting Fee | $16.71 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $995.34 | 71 | $0 (2023) |
| Amgen Inc. | $897.16 | 47 | $0 (2024) |
| GlaxoSmithKline, LLC. | $736.74 | 45 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $703.16 | 41 | $0 (2023) |
| Lilly USA, LLC | $648.10 | 43 | $0 (2023) |
| Novo Nordisk Inc | $528.13 | 30 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $484.09 | 31 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $425.95 | 29 | $0 (2021) |
| PFIZER INC. | $416.09 | 26 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $382.02 | 27 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $93.00 | 4 | GlaxoSmithKline, LLC. ($29.90) |
| 2023 | $545.82 | 27 | Amgen Inc. ($79.71) |
| 2022 | $703.59 | 33 | Boston Scientific Corporation ($179.41) |
| 2021 | $743.45 | 40 | AstraZeneca Pharmaceuticals LP ($84.73) |
| 2020 | $388.64 | 25 | PFIZER INC. ($56.59) |
| 2019 | $2,264 | 131 | Amgen Inc. ($238.75) |
| 2018 | $2,333 | 150 | Novo Nordisk Inc ($274.38) |
| 2017 | $2,079 | 131 | Novartis Pharmaceuticals Corporation ($316.30) |
All Payment Transactions
541 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Inflammation | ||||||
| 01/31/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: VACCINES | ||||||
| 01/30/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: UROLOGY | ||||||
| 09/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: General - Pain Management_NMD | ||||||
| 06/06/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Neuroscience | ||||||
| 06/02/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: RESPIRATORY | ||||||
| 05/24/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Diabetes | ||||||
| 05/17/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: NEUROSCIENCE | ||||||
| 05/06/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Diabetes | ||||||
| 05/01/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: Inflammation | ||||||
| 04/24/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Respiratory | ||||||
| 04/19/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/17/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Diabetes | ||||||
| 04/11/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 04/06/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: NEUROSCIENCE | ||||||
| 04/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: RESPIRATORY | ||||||
| 03/27/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/21/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/19/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/13/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Inflammation | ||||||
| 03/01/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Respiratory | ||||||
| 02/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: RESPIRATORY | ||||||
| 02/15/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,938 | 5,505 | $609,780 | $280,511 |
| 2022 | 22 | 3,450 | 5,727 | $679,290 | $324,219 |
| 2021 | 33 | 4,113 | 6,596 | $745,150 | $349,641 |
| 2020 | 42 | 4,030 | 5,718 | $549,919 | $232,757 |
Total Patients
14,531
Total Services
23,546
Medicare Billing
$1.2M
Procedure Codes
114
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 380 | 944 | $221,840 | $96,545 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 347 | 1,238 | $185,700 | $90,261 | 48.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 264 | 264 | $39,600 | $38,832 | 98.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 64 | $21,720 | $10,179 | 46.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 341 | 808 | $12,120 | $6,787 | 56.0% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 108 | 163 | $17,115 | $6,610 | 38.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 273 | 273 | $13,590 | $5,786 | 42.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 260 | 260 | $12,940 | $5,506 | 42.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 93 | 256 | $19,200 | $4,152 | 21.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 18 | 18 | $3,650 | $3,442 | 94.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 109 | 143 | $17,875 | $3,331 | 18.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 237 | 280 | $22,400 | $3,310 | 14.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 41 | 78 | $4,680 | $1,655 | 35.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 272 | 401 | $6,015 | $1,367 | 22.7% |
| 94690 | Test to measure exhaled air for evaluation of lung function at rest | Office | 2023 | 26 | 26 | $3,900 | $1,117 | 28.6% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 86 | 247 | $6,175 | $950.95 | 15.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 31 | 42 | $1,260 | $680.40 | 54.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 404 | 907 | $213,145 | $97,093 | 45.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 389 | 1,186 | $178,350 | $93,539 | 52.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 202 | 202 | $30,300 | $30,016 | 99.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 458 | 608 | $61,805 | $25,025 | 40.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 226 | 230 | $24,425 | $18,625 | 76.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 144 | 194 | $28,270 | $12,632 | 44.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 49 | 59 | $20,060 | $9,705 | 48.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 214 | 214 | $10,700 | $4,809 | 44.9% |
About Dr. Mohammed Azaz, MD
Dr. Mohammed Azaz, MD is a Internal Medicine healthcare provider based in Commack, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1356331763.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammed Azaz, MD has received a total of $9,151 in payments from pharmaceutical and medical device companies, with $93.00 received in 2024. These payments were reported across 541 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($9,084).
As a Medicare-enrolled provider, Azaz has provided services to 14,531 Medicare beneficiaries, totaling 23,546 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Commack, NY
- Active Since 10/26/2005
- Last Updated 02/24/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1356331763
Products in Payments
- FARXIGA (Drug) $633.06
- ENTRESTO (Drug) $577.39
- XARELTO (Drug) $323.30
- Prolia (Biological) $304.54
- JARDIANCE (Drug) $280.85
- Aimovig (Biological) $280.76
- ANORO (Drug) $242.89
- BREO (Drug) $238.48
- JANUVIA (Drug) $227.09
- Vascepa (Drug) $216.45
- Livalo (Drug) $215.50
- TRELEGY ELLIPTA (Drug) $209.47
- STIOLTO RESPIMAT (Drug) $201.33
- TRULICITY (Drug) $194.85
- CHANTIX (Drug) $190.49
- SYMBICORT (Drug) $181.16
- General - Pain Management (Device) $179.41
- Otezla (Drug) $171.06
- XEOMIN (Biological) $166.67
- TRADJENTA (Drug) $143.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Commack
Dr. Jahan Aghalar, M.d, M.D
Internal Medicine — Payments: $229,012
Internal Medicine $229,012
Zoe Goldberg, Md, MD
Internal Medicine — Payments: $3,895
Internal Medicine $3,895
Paul Berger, M.d, M.D
Internal Medicine — Payments: $3,291
Internal Medicine $3,291
Dr. Parth Patel, Md, MD
Internal Medicine — Payments: $3,245
Internal Medicine $3,245
Alina Ciobanu, M.d, M.D
Internal Medicine — Payments: $3,020
Internal Medicine $3,020
Dr. Jignesh Patel, M.d, M.D
Internal Medicine — Payments: $1,645
Internal Medicine $1,645